Abstract
Background
Collagen X biomarker (CXM) is a novel biomarker of linear growth velocity. We investigated whether CXM correlated with measured growth velocity in children with impaired kidney function.
Methods
We used data from children aged 2 through 16 years old enrolled in the Chronic Kidney Disease in Children (CKiD) study. We assessed the association between CXM level and growth velocity based on height measurements obtained at study visits using linear regression models constructed separately by sex, with and without adjustment for CKD covariates. Linear mixed-effects models were used to capture the between-individual and within-individual CXM changes over time associated with concomitant changes in growth velocity from baseline through follow-up.
Results
A total of 967 serum samples from 209 participants were assayed for CXM. CXM correlated more strongly in females compared to male participants. After adjustment for growth velocity and CKD covariates, only proteinuria in male participants affected CXM levels. Finally, we quantified the between- and within-participant associations between CXM level and growth velocity. A between-participant increase of 24% and 15% in CXM level in females and males, respectively, correlated with a 1 cm/year higher growth velocity. Within an individual participant, on average, 28% and 13% increases in CXM values in females and males, respectively, correlated with a 1 cm/year change in measured growth.
Conclusions
CXM measurement is potentially a valuable aid for monitoring growth in pediatric CKD. However, future research, including studies of CXM metabolism, is needed to clarify whether CXM can be a surrogate of growth in children with CKD.
Graphical Abstract
A higher resolution version of the Graphical abstract is available as Supplementary information
Similar content being viewed by others
References
Wong CS, Gipson DS, Gillen DL et al (2000) Anthropometric measures and risk of death in children with end-stage renal disease. Am J Kidney Dis 36:811–819. https://doi.org/10.1053/ajkd.2000.17674
Gerson AC, Wentz A, Abraham AG et al (2010) Health-related quality of life of children with mild to moderate chronic kidney disease. Pediatrics 125:e349-357. https://doi.org/10.1542/peds.2009-0085
Al-Uzri A, Matheson M, Gipson DS et al (2013) The impact of short stature on health-related quality of life in children with chronic kidney disease. J Pediatr 163:736-741.e1. https://doi.org/10.1016/j.jpeds.2013.03.016
Seikaly MG, Ho PL, Emmett L, Fine RN, Tejani A (2003) Chronic renal insufficiency in children: the 2001 Annual Report of the NAPRTCS. Pediatr Nephrol 18:796–804. https://doi.org/10.1007/s00467-003-1158-5
Tanner JM, Davies PS (1985) Clinical longitudinal standards for height and height velocity for North American children. J Pediatr 107:317–329
Coghlan RF, Oberdorf JA, Sienko S et al (2017) A degradation fragment of type X collagen is a real-time marker for bone growth velocity. Sci Transl Med 9:eaan4669. https://doi.org/10.1126/scitranslmed.aan4669
Coghlan RF, Olney RC, Boston BA, Coleman DT, Johnstone B, Horton WA (2021) Norms for clinical use of CXM, a real-time marker of height velocity. J Clin Endocrinol Metab 106:e255–e264. https://doi.org/10.1210/clinem/dgaa721
Furth SL, Cole SR, Moxey-Mims M et al (2006) Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. Clin J Am Soc Nephrol 1:1006–1015. https://doi.org/10.2215/cjn.01941205
Boone-Heinonen J, Tillotson CJ, O’Malley JP et al (2019) Not so implausible: impact of longitudinal assessment of implausible anthropometric measures on obesity prevalence and weight change in children and adolescents. Ann Epidemiol 31:69-74.e5. https://doi.org/10.1016/j.annepidem.2019.01.006
Rodig NM, McDermott KC, Schneider MF et al (2014) Growth in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children Study. Pediatr Nephrol 29:1987–1995. https://doi.org/10.1007/s00467-014-2812-9
Seikaly MG, Salhab N, Gipson D, Yiu V, Stablein D (2006) Stature in children with chronic kidney disease: analysis of NAPRTCS database. Pediatr Nephrol 21:793–799. https://doi.org/10.1007/s00467-006-0040-7
Furth SL, Abraham AG, Jerry-Fluker J et al (2011) Metabolic abnormalities, cardiovascular disease risk factors, and GFR decline in children with chronic kidney disease. Clin J Am Soc Nephrol 6:2132–2140. https://doi.org/10.2215/cjn.07100810
Pierce CB, Muñoz A, Ng DK, Warady BA, Furth SL, Schwartz GJ (2021) Age- and sex-dependent clinical equations to estimate glomerular filtration rates in children and young adults with chronic kidney disease. Kidney Int 99:948–956. https://doi.org/10.1016/j.kint.2020.10.047
KDOQI (2005) Clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease. Am J Kidney Dis 46:S1–S122
James G, Witten D, Hastie T, Tibshirani R (2021) An introduction to statistical learning: with applications in R. Springer Nature
Kelly A, Winer KK, Kalkwarf H et al (2014) Age-based reference ranges for annual height velocity in US children. J Clin Endocrinol Metab 99:2104–2112. https://doi.org/10.1210/jc.2013-4455
NAPRTCS: 2008 Annual Report. 2008
Brown DD, Dauber A (2021) Growth hormone and insulin-like growth factor dysregulation in pediatric chronic kidney disease. Horm Res Paediatr 94:105–114. https://doi.org/10.1159/000516558
Brown DD, Carroll M, Ng DK et al (2022) Longitudinal associations between low serum bicarbonate and linear growth in children with CKD. Kidney360 3:666–676. https://doi.org/10.34067/kid.0005402021
Silverstein DM (2018) Growth and nutrition in pediatric chronic kidney disease. Front Pediatr 6:205. https://doi.org/10.3389/fped.2018.00205
Fernández-Iglesias Á, López JM, Santos F (2020) Growth plate alterations in chronic kidney disease. Pediatr Nephrol 35:367–374. https://doi.org/10.1007/s00467-018-4160-7
Tönshoff B, Powell DR, Zhao D et al (1997) Decreased hepatic insulin-like growth factor (IGF)-I and increased IGF binding protein-1 and -2 gene expression in experimental uremia. Endocrinology 138:938–946. https://doi.org/10.1210/endo.138.3.4977
Troib A, Landau D, Kachko L, Rabkin R, Segev Y (2013) Epiphyseal growth plate growth hormone receptor signaling is decreased in chronic kidney disease-related growth retardation. Kidney Int 84:940–949. https://doi.org/10.1038/ki.2013.196
Cobo A, López JM, Carbajo E et al (1999) Growth plate cartilage formation and resorption are differentially depressed in growth retarded uremic rats. J Am Soc Nephrol 10:971–979. https://doi.org/10.1681/asn.V105971
Fernández-Fuente M, Santos F, Carbajo-Pérez E et al (2004) Growth plate height of uremic rats is influenced by severity and duration of renal failure. Pediatr Nephrol 19:187–192. https://doi.org/10.1007/s00467-003-1326-7
Breur GJ, VanEnkevort BA, Farnum CE, Wilsman NJ (1991) Linear relationship between the volume of hypertrophic chondrocytes and the rate of longitudinal bone growth in growth plates. J Orthop Res 9:348–359. https://doi.org/10.1002/jor.1100090306
Halberg N, Schraw TD, Wang ZV et al (2009) Systemic fate of the adipocyte-derived factor adiponectin. Diabetes 58:1961–1970. https://doi.org/10.2337/db08-1750
Johannsson G, Bidlingmaier M, Biller BMK et al (2018) Growth Hormone Research Society perspective on biomarkers of GH action in children and adults. Endocr Connect 7:R126-r134. https://doi.org/10.1530/ec-18-0047
Grimberg A, DiVall SA, Polychronakos C et al (2016) Guidelines for growth hormone and insulin-like growth factor-i treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-i deficiency. Horm Res Paediatr 86:361–397. https://doi.org/10.1159/000452150
Acknowledgements
Data in this manuscript were collected by the Chronic Kidney Disease in children prospective cohort study (CKiD) with clinical coordinating centers (Principal Investigators) at Children’s Mercy Hospital and the University of Missouri – Kansas City (Bradley Warady, MD) and Children’s Hospital of Philadelphia (Susan Furth, MD, PhD), Central Biochemistry Laboratory (George Schwartz, MD) at the University of Rochester Medical Center, and data coordinating center (Alvaro Muñoz, PhD and Derek Ng, PhD) at the Johns Hopkins Bloomberg School of Public Health. The CKiD Study is funded by the National Institute of Diabetes and Digestive and Kidney Diseases, with additional funding from the National Institute of Child Health and Human Development, and the National Heart, Lung, and Blood Institute (U01-DK-66143, U01-DK-66174, U24-DK-082194, U24-DK-66116). The CKID website is located at https://www.statepi.jhsph.edu/ckid and a list of CKiD collaborators can be found at https://statepi.jhsph.edu/ckid/site-investigators.
Funding
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): K12HD00139.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflict of interest
A.D consults for Ascendis, Novo Nordisk, BridgeBio, and Biomarin. The remaining authors have no relevant disclosures.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Denver D. Brown and Jennifer Roem are co-first authors.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Brown, D.D., Roem, J., Ng, D.K. et al. Associations between collagen X biomarker and linear growth velocity in a pediatric chronic kidney disease cohort. Pediatr Nephrol 38, 4145–4156 (2023). https://doi.org/10.1007/s00467-023-06047-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-023-06047-0